ciprofloxacin has been researched along with urea in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Hönig, R; Reuter, HD; Thiele, S | 1 |
| el-Kersh, TA; Ramadan, MA; Shibl, AM; Tawfik, AF | 1 |
| Daley, PJ; Lipman, J; Mullany, DV; Rickard, CM; Wallis, SC | 1 |
| Baker, RJ; Brown, EA; Clemenger, M; Senior, H | 1 |
| Blatun, LA; Iakovlev, VP; Svetukhin, AM; Ukhin, SA | 1 |
| Amini, M; Khedmat, H; Yari, F | 1 |
| Ahmad, B; Khan, RH; Parveen, S | 1 |
| Jones, WL; McKittrick, L; Stewart, PS; Sutton, MP | 1 |
| Bedir, O; Caliskan, B; Cayci, T; Guven, A; Korkmaz, A; Ozcan, A; Ozler, M; Surer, I | 1 |
| Brillault, J; Couet, W; Gobin, P; Gontijo, AV; Grégoire, N; Lamarche, I; Marchand, S | 1 |
| Al-Nimer, MS; Alhassani, A; Alnakshbandi, AA | 1 |
| Bhattacharjee, B; Das, A; Das, G; Ramesh, A | 1 |
1 review(s) available for ciprofloxacin and urea
| Article | Year |
|---|---|
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastrointestinal Diseases; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Skin Diseases; Skin Diseases, Bacterial; Soft Tissue Infections; Urea | 2004 |
2 trial(s) available for ciprofloxacin and urea
| Article | Year |
|---|---|
Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
Topics: Acute Kidney Injury; Adult; Aged; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Hemodiafiltration; Humans; Infusions, Intravenous; Intensive Care Units; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Urea | 2001 |
Eradication rate of Helicobacter pylori in dyspeptic patients.
Topics: Analysis of Variance; Anti-Bacterial Agents; Breath Tests; Ciprofloxacin; Drug Therapy, Combination; Dyspepsia; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Single-Blind Method; Tetracycline; Treatment Outcome; Urea | 2005 |
11 other study(ies) available for ciprofloxacin and urea
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
[The effect of ciprofloxacin on epinephrine and collagen induced thrombocyte aggregation in vitro on dialysis patients].
Topics: Ciprofloxacin; Collagen; Creatinine; Epinephrine; Hematocrit; Humans; In Vitro Techniques; Middle Aged; Platelet Aggregation; Platelet Count; Renal Dialysis; Urea | 1988 |
In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity.
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterobacteriaceae; Fluoroquinolones; Norfloxacin; Ofloxacin; Proteus; Providencia; Quinolones; Surface Properties; Urea; Urease | 1995 |
Empirical aminoglycosides for peritonitis do not affect residual renal function.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Creatinine; Drug Administration Schedule; Female; Gentamicins; Humans; Infusions, Parenteral; Kidney; Male; Middle Aged; Peritoneal Dialysis; Peritonitis; Practice Guidelines as Topic; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Urea | 2003 |
Effect of albumin conformation on the binding of ciprofloxacin to human serum albumin: a novel approach directly assigning binding site.
Topics: Binding Sites; Ciprofloxacin; Humans; Molecular Structure; Protein Binding; Protein Conformation; Protein Folding; Serum Albumin; Urea | 2006 |
Chemical and antimicrobial treatments change the viscoelastic properties of bacterial biofilms.
Topics: Biofilms; Cations; Ciprofloxacin; Disinfectants; Elasticity; Glutaral; Materials Testing; Models, Theoretical; Pseudomonas aeruginosa; Rheology; Rifampin; Staphylococcus epidermidis; Urea; Viscosity | 2011 |
Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Aspartate Aminotransferases; Calcitonin; Ciprofloxacin; Creatine; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Fibrosis; Glutathione Peroxidase; Kidney; L-Lactate Dehydrogenase; Male; Malondialdehyde; Neopterin; Oxidative Stress; Ozone; Protein Precursors; Pyelonephritis; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Urea | 2011 |
Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Biopharmaceutics; Bronchoalveolar Lavage Fluid; Cell Line; Ciprofloxacin; Fluoroquinolones; Humans; Macrophages, Alveolar; Male; Moxifloxacin; Piperazines; Rats; Rats, Sprague-Dawley; Urea | 2014 |
The effect of Ultraviolet-B irradiation on the photodegradation of ciprofloxacin and norfloxacin as inhibitors of bacterial DNA replication and cell division in urea medium.
Topics: Cell Division; Ciprofloxacin; Culture Media; DNA Replication; DNA, Bacterial; Norfloxacin; Regression Analysis; Ultraviolet Rays; Urea | 2020 |
Urea-Based Ligand as an Efflux Pump Inhibitor: Warhead to Counter Ciprofloxacin Resistance and Inhibit Collagen Adhesion by MRSA.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Collagen; Humans; Ligands; Methicillin-Resistant Staphylococcus aureus; Multidrug Resistance-Associated Proteins; Staphylococcus aureus; Urea | 2022 |